Toronto company receives first federal funding to study psilocybin


News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.

After decades of prohibition, Canada is finally opening the door to psychedelic research. Canada bans psychedelics nearly 50 years ago, banning the production and use of psychedelic drugs such as psilocybin, the main psychoactive agent in magic mushrooms, and making it nearly impossible to research these drugs. However, the tides have turned in favor of psychedelics in recent years as more and more people have started using them to treat mental health issues including (PTSD) and major depressive disorder.

A Toronto-based company has now received Canada’s first-ever federal government funding to conduct a study on the impact of psilocybin on…

Learn more>>

NOTICE TO INVESTORS: The latest news and updates regarding Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) can be found in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialty content distribution company that (1) aggregates and distributes news and information about the latest developments in all aspects and advances in psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) relies on a team of expert writers to enhance press releases for maximum impact, (4) helps companies manage and optimize social media across a range of platforms, and (5) offers unparalleled business communications solutions. PNW keeps up to date with the latest information and has established a reputation as the go-to for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping public and private companies gain traction with a broad audience of investors, consumers, media and the general public by leveraging our extensive outreach network of over of 5,000 key syndication points. PNW is committed to providing enhanced brand visibility and recognition to companies operating in emerging psychedelic markets.

To receive instant SMS alerts, text “Groovy” to 844-397-5787 (US cell phones only)

For more information, please visit

Please review the full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever posted or republished:

Do you have questions or are you interested in working with PNW? Ask our editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.


Comments are closed.